speb/financial-data huggingface dataset:
MEDP cash_flow (quarterly, 2026-06-30) — Deferred Tax: 4281000.00
MEDP cash_flow (quarterly, 2026-06-30) — Depreciation: 6555000.00
MEDP cash_flow (quarterly, 2026-06-30) — Depreciation Amortization Depletion: 6710000.00
MEDP income_statement (quarterly, 2026-06-30) — Depreciation Amortization Depletion Income Statement: 6710000.00
MEDP cash_flow (quarterly, 2026-06-30) — Depreciation And Amortization: 6710000.00
MEDP income_statement (quarterly, 2026-06-30) — Depreciation And Amortization In Income Statement: 6710000.00
MEDP income_statement (quarterly, 2026-06-30) — Depreciation Income Statement: 6555000.00
MEDP income_statement (quarterly, 2026-06-30) — Diluted Average Shares: 28554000.00
MEDP income_statement (quarterly, 2026-06-30) — Diluted EPS: 4.25
MEDP income_statement (quarterly, 2026-06-30) — Diluted NI Availto Com Stockholders: 121362000.00
MEDP income_statement (quarterly, 2026-06-30) — EBIT: 146824000.00
MEDP income_statement (quarterly, 2026-06-30) — EBITDA: 153534000.00
MEDP cash_flow (quarterly, 2026-06-30) — Effect Of Exchange Rate Changes: 221000.00
MEDP cash_flow (quarterly, 2026-06-30) — End Cash Position: 502688000.00
MEDP cash_flow (quarterly, 2026-06-30) — Financing Cash Flow: -288340000.00
MEDP cash_flow (quarterly, 2026-06-30) — Free Cash Flow: 138100000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Gains Losses Not Affecting Retained Earnings: -7082000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Goodwill: 662396000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Goodwill And Other Intangible Assets: 695506000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Gross PPE: 282963000.00
MEDP income_statement (quarterly, 2026-06-30) — Gross Profit: 201637000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Invested Capital: 433861000.00
MEDP cash_flow (quarterly, 2026-06-30) — Investing Cash Flow: -23885000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Long Term Capital Lease Obligation: 120100000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Long Term Debt And Capital Lease Obligation: 120100000.00
MEDP cash_flow (quarterly, 2026-06-30) — Net Common Stock Issuance: -294764000.00
MEDP income_statement (quarterly, 2026-06-30) — Net Income: 121362000.00
MEDP income_statement (quarterly, 2026-06-30) — Net Income Common Stockholders: 121362000.00
MEDP income_statement (quarterly, 2026-06-30) — Net Income Continuous Operations: 121362000.00
MEDP income_statement (quarterly, 2026-06-30) — Net Income From Continuing And Discontinued Operation: 121362000.00
MEDP income_statement (quarterly, 2026-06-30) — Net Income From Continuing Operation Net Minority Interest: 121362000.00
MEDP cash_flow (quarterly, 2026-06-30) — Net Income From Continuing Operations: 121362000.00
MEDP income_statement (quarterly, 2026-06-30) — Net Income Including Noncontrolling Interests: 121362000.00
MEDP income_statement (quarterly, 2026-06-30) — Net Interest Income: 4986000.00
MEDP income_statement (quarterly, 2026-06-30) — Net Non Operating Interest Income Expense: 4986000.00
MEDP cash_flow (quarterly, 2026-06-30) — Net Other Investing Changes: 26000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Net PPE: 282963000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Net Tangible Assets: -261645000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Non Current Deferred Assets: 3231000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Non Current Deferred Liabilities: 8207000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Non Current Deferred Taxes Assets: 3231000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Non Current Deferred Taxes Liabilities: 8207000.00
MEDP income_statement (quarterly, 2026-06-30) — Normalized EBITDA: 153534000.00
MEDP income_statement (quarterly, 2026-06-30) — Normalized Income: 121362000.00
MEDP cash_flow (quarterly, 2026-06-30) — Operating Cash Flow: 162011000.00
MEDP income_statement (quarterly, 2026-06-30) — Operating Income: 146824000.00
MEDP income_statement (quarterly, 2026-06-30) — Operating Revenue: 707331000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Ordinary Shares Number: 27910605.00
MEDP balance_sheet (quarterly, 2026-06-30) — Other Current Assets: 105800000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Other Current Liabilities: 42104000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Other Equity Adjustments: -7082000.00
MEDP income_statement (quarterly, 2026-06-30) — Other Income Expense: -147000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Other Intangible Assets: 33110000.00
MEDP cash_flow (quarterly, 2026-06-30) — Other Non Cash Items: 5908000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Other Non Current Assets: 25196000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Other Non Current Liabilities: 59584000.00
MEDP income_statement (quarterly, 2026-06-30) — Other Non Operating Income Expenses: -147000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Other Properties: 282963000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Other Receivables: 21265000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Payables: 37527000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Payables And Accrued Expenses: 409175000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 79428000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Preferred Stock: 0.00
MEDP income_statement (quarterly, 2026-06-30) — Pretax Income: 151663000.00
MEDP cash_flow (quarterly, 2026-06-30) — Proceeds From Stock Option Exercised: 6424000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Receivables: 441797000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Receivables Adjustments Allowances: -28000.00
MEDP income_statement (quarterly, 2026-06-30) — Reconciled Cost Of Revenue: 505694000.00
MEDP income_statement (quarterly, 2026-06-30) — Reconciled Depreciation: 6710000.00
MEDP cash_flow (quarterly, 2026-06-30) — Repurchase Of Capital Stock: -294764000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Retained Earnings: -511368000.00
MEDP income_statement (quarterly, 2026-06-30) — Selling General And Administration: 48103000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Share Issued: 27910605.00
MEDP cash_flow (quarterly, 2026-06-30) — Stock Based Compensation: 4348000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Stockholders Equity: 433861000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Tangible Book Value: -261645000.00
MEDP income_statement (quarterly, 2026-06-30) — Tax Effect Of Unusual Items: 0.00
MEDP income_statement (quarterly, 2026-06-30) — Tax Provision: 30301000.00
MEDP income_statement (quarterly, 2026-06-30) — Tax Rate For Calcs: 0.20
MEDP balance_sheet (quarterly, 2026-06-30) — Total Assets: 2057181000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Total Capitalization: 433861000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Total Debt: 120100000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Total Equity Gross Minority Interest: 433861000.00
MEDP income_statement (quarterly, 2026-06-30) — Total Expenses: 560507000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Total Liabilities Net Minority Interest: 1623320000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Total Non Current Assets: 1006896000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Total Non Current Liabilities Net Minority Interest: 187891000.00
MEDP income_statement (quarterly, 2026-06-30) — Total Operating Income As Reported: 146824000.00
MEDP income_statement (quarterly, 2026-06-30) — Total Other Finance Cost: -4986000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Treasury Stock: 12151000.00
MEDP balance_sheet (quarterly, 2026-06-30) — Working Capital: -385144000.00
MEDPLUS.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -3084610000.00
MEDPLUS.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 11831470000.00
MEDPLUS.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -7690000.00
MEDPLUS.NS income_statement (annual, 2022-03-31) — Amortization: 11240000.00
MEDPLUS.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 8567590000.00
MEDPLUS.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 214550000.00
MEDPLUS.NS cash_flow (annual, 2022-03-31) — Change In Payable: 1116520000.00
MEDPLUS.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 8991330000.00
MEDPLUS.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 168800000.00
MEDPLUS.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 68050000.00
MEDPLUS.NS income_statement (annual, 2022-03-31) — Impairment Of Capital Assets: 260000.00
MEDPLUS.NS income_statement (annual, 2022-03-31) — Interest Income: 137320000.00
MEDPLUS.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 137320000.00
MEDPLUS.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 143300000.00
MEDPLUS.NS balance_sheet (annual, 2022-03-31) — Long Term Debt: 0.00
MEDPLUS.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 1884080000.00
MEDPLUS.NS balance_sheet (annual, 2022-03-31) — Net Debt: 1212270000.00
MEDPLUS.NS cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: -52650000.00
MEDPLUS.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: 10000.00
MEDPLUS.NS cash_flow (annual, 2022-03-31) — Net Preferred Stock Issuance: 0.00
MEDPLUS.NS cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: -52650000.00
MEDPLUS.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 203850000.00
MEDPLUS.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 862800000.00
MEDPLUS.NS cash_flow (annual, 2022-03-31) — Other Cash Adjustment Outside Changein Cash: -10000.00
MEDPLUS.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 6070000.00
MEDPLUS.NS balance_sheet (annual, 2022-03-31) — Other Non Current Liabilities: -200000.00
MEDPLUS.NS balance_sheet (annual, 2022-03-31) — Other Payable: 554530000.00
MEDPLUS.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 399040000.00
MEDPLUS.NS income_statement (annual, 2022-03-31) — Other Special Charges: -37090000.00
MEDPLUS.NS cash_flow (annual, 2022-03-31) — Preferred Stock Issuance: 0.00
MEDPLUS.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 132130000.00
MEDPLUS.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
MEDPLUS.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 149830000.00
MEDPLUS.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 2530000.00
MEDPLUS.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 2530000.00
MEDPLUS.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 1637760000.00
MEDPLUS.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 473480000.00
MEDPLUS.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 642280000.00
MEDPLUS.NS income_statement (annual, 2022-03-31) — Special Income Charges: 36830000.00
MEDPLUS.NS income_statement (annual, 2022-03-31) — Total Unusual Items: 36830000.00
MEDPLUS.NS income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: 36830000.00
MEDPLUS.NS balance_sheet (annual, 2022-03-31) — Work In Process: 2610000.00
MEDPLUS.NS income_statement (annual, 2022-03-31) — Write Off: 260000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — +Operating Expense: 8836600000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — +Total Revenue: 45286800000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 2601440000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 66840000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -4711310000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 11874140000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -6450000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Amortization: 17110000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 17110000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 1000000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 119305676.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Basic EPS: 4.17
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: -1212270000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 12274770000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -1690050000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 8999240000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 238610000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 2283750000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 2886740000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 2283750000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -2291030000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -139270000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 315040000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Change In Payable: 278210000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -2155840000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 3496020000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Common Stock: 238610000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 14911780000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 11890000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 274270000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 35576880000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Current Assets: 14807210000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 987440000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Current Debt: 0.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 987440000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 4765830000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 260640000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Depreciation: 1803240000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 1820350000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 1815560000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 1798450000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 119650943.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Diluted EPS: 4.17
MEDPLUS.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 497630000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — EBIT: 1301900000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — EBITDA: 3122250000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — End Cash Position: 2283750000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -1702490000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 11197740000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -785970000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -38460000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 209530000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Goodwill: 414510000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 489890000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 73290000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 15891030000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Gross Profit: 9709920000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Impairment Of Capital Assets: 1080000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Interest Expense: 830270000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 830270000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Interest Income: 277880000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 277880000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -830270000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 224700000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Inventory: 11440870000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 14911780000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: 4294430000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 1000000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 11890000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 151070000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 8011800000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 8011800000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 277460000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 3190920000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Minority Interest: -6770000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Minority Interests: -3420000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 11890000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Net Income: 497630000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 497630000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 501050000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 497630000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 497630000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 471630000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 501050000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Net Interest Income: -552390000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 5758180000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -552390000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Net PPE: 11179720000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -1688450000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 14421890000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 658120000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 277460000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 830860000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 3084780000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Normalized Income: 471401000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 904080000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Operating Income: 873320000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Operating Revenue: 45286800000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 119077714.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 316990000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 142980000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 304350000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 75380000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 50000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 549160000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: -110000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 112340000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 934360000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Other Payable: 669630000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Other Properties: 8021990000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 67720000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 602990000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Other Special Charges: -38550000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Payables: 3281360000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Pension And Employee Benefit Expense: 162560000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 345040000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Pretax Income: 471630000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 11760000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -1154870000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -1690050000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 235690000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 35576880000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 1820350000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 1280000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 1280000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 2138730000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 6913050000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 1600000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 677560000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 887090000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Share Issued: 119305676.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Special Income Charges: 37470000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Stock Based Compensation: 221190000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 14911780000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 14421890000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 11241000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Tax Provision: -29420000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.30
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 1500000.00
MEDPLUS.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -139350000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Total Assets: 27967180000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 14911780000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Total Debt: 8999240000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 14905010000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Total Expenses: 44413480000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 13062170000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 13159970000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 8296340000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 10290000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 37470000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 37470000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Treasury Shares Number: 227962.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Work In Process: 7440000.00
MEDPLUS.NS balance_sheet (annual, 2023-03-31) — Working Capital: 10041380000.00
MEDPLUS.NS income_statement (annual, 2023-03-31) — Write Off: 1080000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — +Operating Expense: 10503790000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — +Total Revenue: 55735420000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 2530350000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 122510000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -6120780000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 12086520000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -6490000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Amortization: 18290000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 18290000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 51000000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 119386896.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Basic EPS: 5.48
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 2283750000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 14120500000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -843990000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 10095690000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 239070000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 912090000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 1650350000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 912090000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -1961470000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -317860000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 59330000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Change In Payable: 9160000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -2311010000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -1371660000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Common Stock: 239070000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 15779320000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 72310000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 67770000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 43916280000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Current Assets: 15675520000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 1414860000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Current Debt: 0.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 1414860000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 5259350000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 306730000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Depreciation: 2223850000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 2242140000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 2242140000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 2223850000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 120024688.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Diluted EPS: 5.45
MEDPLUS.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 654730000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — EBIT: 1698760000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — EBITDA: 3940900000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — End Cash Position: 912090000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -1981040000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 13102730000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 593380000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: 190000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -40690000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 251340000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Goodwill: 414510000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 515300000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 129000000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 18147760000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Gross Profit: 11819140000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Interest Expense: 964330000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 964330000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Interest Income: 209360000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 209360000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -964330000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 136040000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Inventory: 13402340000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 15779320000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -827990000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 51000000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 72310000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 151070000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 8680830000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 8680830000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 324890000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 3808420000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Minority Interest: -5730000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Minority Interests: -1040000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 72310000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Net Income: 654730000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 654730000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 655770000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 654730000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 654730000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 734430000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 655770000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Net Interest Income: -754970000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -135600000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -754970000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Net PPE: 12026980000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -828430000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 15264020000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 849940000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 324890000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 928890000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 3901920000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Normalized Income: 619924893.18
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 1437370000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Operating Income: 1315350000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Operating Revenue: 55735420000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 119418586.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 355310000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 137750000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 303620000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 100790000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 753360000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: -110000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 134710000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 1142500000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Other Payable: 707800000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Other Properties: 11959100000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 105600000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 738260000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Other Special Charges: -41140000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Payables: 3242290000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Pension And Employee Benefit Expense: 193710000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 394720000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Pretax Income: 734430000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 14270000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -1096440000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -843990000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 289610000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 43916280000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 2242140000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 970000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 970000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 2792910000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 960840000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 15560000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 982780000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 1234120000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Share Issued: 119536952.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Special Income Charges: 38980000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Stock Based Compensation: 141040000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 15779320000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 15264020000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 4174893.18
MEDPLUS.NS income_statement (annual, 2024-03-31) — Tax Provision: 78660000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.11
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 460000.00
MEDPLUS.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -292230000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Total Assets: 30048010000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 15779320000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Total Debt: 10095690000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 15773590000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Total Expenses: 54420070000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 14274420000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 14372490000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 9015070000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 4140000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 38980000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 38980000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 118366.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Work In Process: 10000000.00
MEDPLUS.NS balance_sheet (annual, 2024-03-31) — Working Capital: 10416170000.00
MEDPLUS.NS income_statement (annual, 2024-03-31) — Write Off: 2160000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 3056470000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 179750000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 911470000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 10297440000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 239090000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 1239730000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 3030660000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 239090000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 16363010000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 112470000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 17123860000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 1113090000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 1113090000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 5633510000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 318110000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Goodwill: 414510000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 515790000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 11909850000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 13407050000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 16363010000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 911470000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 9184350000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 9184350000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 370920000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: -6290000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 11909850000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 15847220000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 922040000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 119469207.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 506400000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 251580000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 16123920000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 101280000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 39330000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 11797380000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 1790930000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Payables: 3060620000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 119547156.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 16363010000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 15847220000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 0.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 31550680000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 16363010000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 10297440000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 16356720000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 15193960000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 14426820000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 9560450000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 4150000.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Treasury Shares Number: 77949.00
MEDPLUS.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 11490350000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 3208090000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 15614460000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 119494792.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 3.84
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 11705820000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 624690000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 624690000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 120120419.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 3.82
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 458860000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — EBIT: 825710000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — EBITDA: 1450400000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 3908640000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 259710000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 259710000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Minority Interests: 160000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Net Income: 458860000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 458860000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 458700000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 458860000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 458860000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 458700000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -259710000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -259710000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 1450400000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 458860000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Operating Income: 700550000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 15614460000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 125160000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 686580000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 566000000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 11705820000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 624690000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 107300000.00
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.19
MEDPLUS.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 14913910000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — +Operating Expense: 12082860000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 3288070000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — +Total Revenue: 60874640000.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 15096090000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 2989590000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 2989590000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 79560000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 79560000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -7429240000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -7429240000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 12246320000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 12246320000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -4690000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -4690000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Amortization: 34970000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 34970000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 23570000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 23570000.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 119587355.00
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 118831019.00
MEDPLUS.NS income_statement (annual, 2025-03-31) — Basic EPS: 12.57
MEDPLUS.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 4.32
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 912090000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 15869370000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 15869370000.00
MEDPLUS.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -594500000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 11198020000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 11198020000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 239390000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 239390000.00
MEDPLUS.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 860520000.00
MEDPLUS.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 860520000.00